STRS Ohio’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-17,000
Closed -$698K 2225
2021
Q3
$698K Buy
17,000
+10,900
+179% +$597K ﹤0.01% 1360
2021
Q2
$345K Hold
6,100
﹤0.01% 1674
2021
Q1
$256K Hold
6,100
﹤0.01% 1754
2020
Q4
$427K Buy
6,100
+5,100
+510% +$210K ﹤0.01% 1539
2020
Q3
$28K Hold
1,000
﹤0.01% 2047
2020
Q2
$29K Buy
+1,000
New +$26.1K ﹤0.01% 1986
2016
Q4
Sell
-600
Closed -$8K 1941
2016
Q3
$8K Sell
600
-1,600
-73% -$32.8K ﹤0.01% 1874
2016
Q2
$53K Hold
2,200
﹤0.01% 1763
2016
Q1
$75K Buy
+2,200
New +$57.8K ﹤0.01% 1721

Other funds holding EDIT

STRS Ohio's EDIT Position: Q4 2021 in Review

STRS Ohio sold out of Editas Medicine (EDIT) in Q4 2021, closing a stake of 17,000 shares — an estimated $698K sold.

STRS Ohio first reported a position in EDIT in Q1 2016 and held it in 9 quarters. The position peaked at $698K in Q3 2021. 305 funds tracked by Wall St. Rank hold EDIT as of Q4 2021.

  • STRS Ohio reported no remaining Editas Medicine position as of Q4 2021 after selling out during the quarter.
  • STRS Ohio sold 17,000 Editas Medicine shares in Q4 2021, an estimated $698K.
  • STRS Ohio first reported a position in Editas Medicine in Q1 2016 and held it in 9 quarters.
  • STRS Ohio's Editas Medicine position peaked at $698K in Q3 2021.
  • 305 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2021.

Based on STRS Ohio's 13F filing for Q4 2021, filed 24 Jan 2022.